logo
Select company
Select metric
-4.97%Return on Equity
VS
Market
37
Sector
76
Industry
51
History
100
$ 5.9Close
$ 3.57 - $ 1.19K 52-Week Range
Ticker Information

Ticker

STSS

Company Name

SHARPS TECHNOLOGY INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

SHARPS TECHNOLOGY INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STSS - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 14.54M$ -723.35K-4.97%
3/31/2025$ 10.14M$ -6.38M-63%
12/31/2024$ 2M$ -9.3M-465.71%
9/30/2024$ 6.51M$ -7.87M-120.99%
6/30/2024$ 7.22M$ -8.21M-113.74%
3/31/2024$ 6.86M$ -8.71M-126.99%
12/31/2023$ 7.93M$ -9.84M-124.04%
9/30/2023$ 10.6M$ -7.59M-71.63%
6/30/2023$ 8.69M$ -7.97M-91.67%
3/31/2023$ 10.97M$ -4.88M-44.51%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SHARPS TECHNOLOGY INC's latest trailing twelve months (TTM) ROE stands at -148.73%.
  • Over the past 5 years, SHARPS TECHNOLOGY INC's average ROE has been -118.68%.
  • The median ROE for SHARPS TECHNOLOGY INC during this period was -102.7%
  • SHARPS TECHNOLOGY INC reached its highest ROE over the past 5 years at -4.97%.
  • The lowest ROE recorded by SHARPS TECHNOLOGY INC in the same timeframe -465.71%

SHARPS TECHNOLOGY INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
GCTK : GLUCOTRACK INC -389.1%HSDT : HELIUS MEDICAL TECHNOLOGIES INC -353.22%VIVS : VIVOSIM LABS INC -20.83%AIM : AIM IMMUNOTECH INC -HCWB : HCW BIOLOGICS INC -SILO : SILO PHARMA INC -99.55%ACON : ACLARION INC -49.76%PTIX : PROTAGENIC THERAPEUTICS INC -ADTX : ADITXT INC -285.12%TCRT : ALAUNOS THERAPEUTICS INC -109.07%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for SHARPS TECHNOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -4.66M ] / Equity [ $ 3.14M ]
(=) ROE [ -148.73% ]

STSS - Return on Equity, Last 5 years

-465.71%

Minimum

Dec 31, 2024

-4.97%

Maximum

Jun 30, 2025

-118.68%

Average

-102.7%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%